-
Most Recent
Healthcare Stocks
Healthcare encompasses a wide range of organized services to prevent, treat, and diagnose medical needs and mental illnesses. The $336 billion market is expected to grow at a compound annual growth rate of 8% until 2030, demonstrating the necessity of adequate healthcare. Healthcare companies, ranging from retailer CVS to insurance giant UnitedHealth, provide these services to a massive customer base.
7 Recession-Resistant Stocks to Hold Onto for Dear Life in 2024
These seven recession-resistant stocks offer stability and potential growth even in challenging economic conditions.
7 Dependable Dividend Stocks for Long-Term Income
Explore the best dividend stocks for long-term income excelling in the healthcare, retail, tobacco and home improvement markets.
3 Pharmaceutical Stocks That Can Surge Higher Even if The Markets Correct
These are the pharmaceutical stocks to buy as they represent undervalued companies with a deep clinical pipeline that will support growth.
Other industries you might be interested in
Recent Healthcare Stocks Articles
Fidelity Select Pharmaceutical Mutual Fund Offers Diversified Drug Play
The Fidelity Select Pharmaceutical Portfolio offers a diversified group of big pharma stocks and biotech investments that give investors a way to play the entire sector easily.
Best Buy Rallies as Dollar Thrifty Gets a Flat
Trading midday sees action in Best Buy (NYSE: BBY), Kellogg (NYSE: K), Dollar Thrifty (NYSE: DTG) and FactSet Research (NYSE: FDS).
BioMimetic Has Suitors Lying in Wait
A key FDA OK could have the buyout offers rolling in.
Can Investors Diagnose Anything from Cancer Drug Summit?
The recently concluded American Society for Clinical Oncology is considered to be the landmark event where the biggest info is shared. So what was the news?
Pharmaceutical Companies Hit New Highs, Solar Stocks New Lows
Solar stocks are among the investments hitting new 52 week lows today in the stock market as pharmaceutical companies hit new highs.
Bob Evans Rebounds, Abercrombie gets Rejected
Midday stock movers led by Bob Evans Farms (NASDAQ: BOBE), Ciena (NASDAQ: CIEN) and Abercrombie & Fitch (NYSE: ANF).
New AIDS Therapies May Shake Up Big Pharma Profits
Vaccines and transplants may usher in new players
Beware These 8 False Bargain Stocks
Don't be tricked into thinking that these falling stocks present great buying opportunities. These so-called bargains from some of the hottest sectors are anything but.
Ziopharm Has Help With Deep Pockets
This biotech small-cap could soon be a cancer-drug player.
Selloff in Pharma United Therapeutics and Exelixis
Volume leaders in midday trading included Credicorp (NYSE: BAP), Lorillard (NYSE: LO), United Therapeutics Corp. (NASDAQ: UTHR).
Rubbermaid Bounced Out in Midday Trading
Stocks moving significantly at midday include Rubbermaid (NYSE: NWL), Arch Coal (NYSE: ACI), Quicksilver (NYSE: ZQK).
Biotech Royalty Paying 9% Dividend Yield
Technology permitting the deployment of animal-derived antibodies in human patients feeds PDL BioPharma’s rich royalty stream.
Artificial Heart Stocks Thoratec & Heartware Vie for Your Love
Both artificial heart developers THOR and HTWR have had a volatile run lately. But in this feud, perhaps only one device maker can win Wall Street's affections.
Could Legalized Pot Give Big Pharma a Much-Needed Boost?
Medical marijuana is big business where it's legalized, and if major pharmaceutical companies could get a share of the market they could see a big boost.
Johnson & Johnson Stock a Buy With Healthy Performance Ahead
After some recalls, Johnson & Johnson earnings are back on track. Along with a nice dividend, that makes it a good buy.
